| 1 |
Natural Molecules in the Management of Polycystic Ovary Syndrome (PCOS): An Analytical Review |
|
|
| Matteo Iervolino,Elisa Lepore,Gianpiero Forte,Antonio Simone Laganà,Giovanni Buzzaccarini,Vittorio Unfer |
|
| Nutrients. 2021; 13(5): 1677 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 2 |
Tailoring treatment for PCOS phenotypes |
|
|
| Georgios Papadakis,Eleni A. Kandaraki,Anna Garidou,Maria Koutsaki,Olga Papalou,Evanthia Diamanti-Kandarakis,Melpomeni Peppa |
|
| Expert Review of Endocrinology & Metabolism. 2020; : 1 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 3 |
The effects of flaxseed supplementation on metabolic status in women with polycystic ovary syndrome: a randomized open-labeled controlled clinical trial |
|
|
| Fatemeh Haidari,Nasrin Banaei-Jahromi,Mehrnoosh Zakerkish,Kambiz Ahmadi |
|
| Nutrition Journal. 2020; 19(1) |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 4 |
Dietary a-Linolenic Acid-Rich Flaxseed Oil Exerts Beneficial Effects on Polycystic Ovary Syndrome Through Sex Steroid Hormones—Microbiota—Inflammation Axis in Rats |
|
|
| Ting Wang,Liping Sha,Yiwei Li,Lili Zhu,Zhen Wang,Ke Li,Haixia Lu,Ting Bao,Li Guo,Xiaoxia Zhang,Hao Wang |
|
| Frontiers in Endocrinology. 2020; 11 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 5 |
The effects of alpha-lipoic acid supplementation on fasting glucose and lipid profiles among patients with stroke: a systematic review and meta-analysis of randomized controlled trials |
|
|
| Reza Tabrizi,Afshin Borhani-Haghighi,Naghmeh Mirhosseini,Kamran B. Lankarani,Ahmad Naghibzadeh-Tahami,Maryam Akbari,Seyed Taghi Heydari,Mojgan Sangari,Fariba Kolahdooz,Fariba Raygan,Zatollah Asemi |
|
| Journal of Diabetes & Metabolic Disorders. 2019; |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 6 |
Effectiveness of Omega-3 fatty acid for polycystic ovary syndrome: a systematic review and meta-analysis |
|
|
| Kailin Yang,Liuting Zeng,Tingting Bao,Jinwen Ge |
|
| Reproductive Biology and Endocrinology. 2018; 16(1) |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 7 |
Improvement of insulin resistance via increase of GLUT4 and PPAR? in metabolic syndrome-induced rats treated with omega-3 fatty acid or l
-carnitine |
|
|
| Eman Adel Zayed,Afaf A. AinShoka,Kamal A. El Shazly,Hekma A. Abd El Latif |
|
| Journal of Biochemical and Molecular Toxicology. 2018; : e22218 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 8 |
The effects of fish oil omega-3 fatty acid supplementation on mental health parameters and metabolic status of patients with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial |
|
|
| Mehrdad Amini,Fereshteh Bahmani,Fatemeh Foroozanfard,Zahra Vahedpoor,Amir Ghaderi,Mohsen Taghizadeh,Hassan Karbassizadeh,Zatollah Asemi |
|
| Journal of Psychosomatic Obstetrics & Gynecology. 2018; : 1 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 9 |
Can omega-3 polyunsaturated fatty acids improve metabolic profile in polycystic ovary syndrome (PCOS)? |
|
|
| Bradley J. McEwen |
|
| Advances in Integrative Medicine. 2017; 4(2): 82 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
